TrianglePUBLICATIONS · 8315425
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1993 Jul
- First author
- Antman K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Antman K
- type
- Author
- name
- Crowley J
- type
- Author
- name
- Balcerzak SP
- type
- Author
- name
- Rivkin SE
- type
- Author
- name
- Weiss GR
- type
- Author
- name
- Elias A
- type
- Author
- name
- Natale RB
- type
- Author
- name
- Cooper RM
- type
- Author
- name
- Barlogie B
- type
- Author
- name
- Trump DL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Antman K
- type
- Author
- name
- Crowley J
- type
- Author
- name
- Balcerzak SP
- type
- Author
- name
- Rivkin SE
- type
- Author
- name
- Weiss GR
- type
- Author
- name
- Elias A
- type
- Author
- name
- Natale RB
- type
- Author
- name
- Cooper RM
- type
- Author
- name
- Barlogie B
- type
- Author
- name
- Trump DL
- type
- Author
- bibliography ids
- nci-bib-23d8d500ea98cd4ad6f2bf1c
- book metadata
- content sha256
- 0783bb78f1fc345f023ee8893f0d851935bcd9abe3b6f57fdef078c79b9eb327
- document type
- citation
- dois
- 10.1200/JCO.1993.11.7.1276
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:8315425
- immutable id
- pubmed:8315425@0783bb78f1fc345f023ee8893f0d851935bcd9abe3b6f57fdef078c79b9eb327
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 7
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1276-85
- volume
- 11
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 8315425
- provenance
- batch id
- 83ec39f94a925b232876
- provider
- NCBI PubMed ESummary
- record sha256
- 5e4b373f80039b0f244727fbc7598423296c2ffa1e4ceabf43eff73c426b762a
- response sha256
- 9cea37bf3451de6aa8c54c490de635080a496054249095b8c254be0e69164eca
- retrieved at
- 2026-09-09T23:45:20.996485+00:00
- publication date
- display
- 1993 Jul
- precision
- month
- year
- 1993
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/8315425/
- title
- An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
Preserved source evidence · Not medical advice